Company profile
Akamis Bio
Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer
- Industry
- Biotechnology Research
- Employees
- 36
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2010
- LinkedIn followers
- 8,357
- Office locations
- 1
Akamis Bio company summary
Akamis Bio is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2010. On LinkedIn the company has around 36 employees and 8,357 followers. Its listed specialties include Immuno-oncology and Re-programming the Tumor Microenvironment.
What technology does Akamis Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Akamis Bio
Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com
Specialties
Where is Akamis Bio located?
Akamis Bio lists 1 location.
Compare companies similar to Akamis Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Akamis Bio akamisbio.com | Biotechnology Research | 36 | 2010 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Akamis Bio
What does Akamis Bio do?
Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com
How many employees does Akamis Bio have?
Akamis Bio has around 36 employees on LinkedIn.
Where is Akamis Bio headquartered?
Akamis Bio is headquartered in Cambridge, Massachusetts.
When was Akamis Bio founded?
Akamis Bio was founded in 2010.
Build a lead list from companies like Akamis Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.